Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
CN Stock MarketDetailed Quotes
688710 Shanghai InnoStar Bio-tech
- 31.76
- +0.33+1.05%
Market Closed Apr 29 15:00 CST
4.48BMarket Cap30.54P/E (TTM)
32.45High31.39Low8.55KlotVolume31.40Open31.43Pre Close27.24MTurnover3.03%Turnover Ratio23.03P/E (Static)140.98MShares50.1352wk High1.89P/B895.50MFloat Cap22.5252wk Low37.72Limit Up28.20MShs Float50.13Historical High25.14Limit Down3.37%Amplitude22.52Historical Low--Dividend TTM31.86Avg Price3.81KlotAsk--Div YieldTTM100Lot Size4.46KlotBid
About Shanghai InnoStar Bio-tech Company
The company was founded in 2010. Adhering to the core values of “scientific leadership, quality first, honesty and dedication, unity and mutual trust”, seeking survival through quality, winning customers through reputation, promoting development through innovation, and creating efficiency through management, it has successively passed GLP certification by NMPA, AAALAC certification, GLP certification by the Dutch government of an OECD member country, GLP certification by the US FDA, and CAP certification by the American Society of Pathologists. It is one of the new drug safety evaluation agencies with a complete quality control system and complete service content in China. The company's shares were listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on September 3, 2024.
Company Profile
Short Name-A益诺思生物
Company NameShanghai InnoStar Bio-tech Co., Ltd.
Listing DateSep 3, 2024
Issue Price19.06
Shares Offered35.24M share(s)
FoundedMay 12, 2010
Chairmanshuyuan wei
Legal Representativeyan chang
General Manageryan chang
Secretaryyan li
Employees1085
ProvinceShang Hai Shi
Phone021-50801259
Office Address199 Guo Shoujing Road, China (Shanghai) Pilot Free Trade Zone
Zip Code201203
Registered AddressRoom 106, 199 Guo Shoujing Road, China (Shanghai) Pilot Free Trade Zone
Fax021-50801259
Emailbo@innostar.cn
Websitehttps://www.innostar.cn/
Business License91310000555907546T
BusinessThe issuer is a comprehensive research and development service (CRO) enterprise specializing in providing biomedical non-clinical research services. As one of the earliest domestic companies that also has NMPA GLP certification, OECD GLP certification, and US FDA GLP inspection, it is in line with international standards, has competitive international service capabilities within the industry, and provides a full range of new drug research services that meet domestic and international declaration standards for pharmaceutical companies and research institutions around the world. The company's services mainly cover the three major segments of biomedicine early pharmacogenicity evaluation, non-clinical research, and clinical testing and translational research. Among them, the non-clinical research section specifically includes non-clinical safety evaluation, non-clinical pharmacokinetic research, and non-clinical pharmacodynamics research.
Company Executives
- Name
- Position
- Salary
- shuyuan wei
- Chairman, Directors
- --
- yan chang
- Directors, General Manager
- 1.78M
- weiping zhuang
- Directors
- --
- yong zhang
- Directors
- --
- weigen lu
- Directors
- --
- shengcai li
- Independent Directors
- 80.00K
- guoqin fan
- Independent Directors, Member of the Strategic Planning Committee, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
- --
- rong shao
- Independent Directors
- 80.00K
- yan li
- Board Secretary
- 721.70K
- xue bai
- Securities Affairs Representative
- --
- li gao
- Chairman of the Supervisory Board, Auditors
- --
- taotao ying
- Auditors
- --
- hua li
- Deputy General Manager
- 963.80K
- xiaohong gao
- Chief Financial Officer
- 1.18M
- wenjun yang
- Employee Supervisors
- 410.70K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts